Literature DB >> 4142544

Relation of human blood-groups MN to cancer cell surface antigens and to receptors for oncogenic viruses.

G F Springer, P R Desai.   

Abstract

It has been shown by us that the human blood-group MN antigenic determinants are not the products of allelomorphic genes as believed so far, but that N is the precursor substance of M and that the allelomorph to the M gene is amorph. The determinant structure of the N antigen is branched and possesses as non-reducing termini beta-d-galactopyranosyl (Gal) and alpha-N-acetylneuraminic acid (NANA) linked to beta-Gal. The M substance differs from N only in that alpha-NANA covers the terminal beta-Gal of the N determinant. Vicia graminea anti-N reacts with terminal beta-Gal of the N antigen as well as its precursor. A human blood-group N-like antigen in the cell surface of the TA3 mammary adenocarcinoma (ascites form) has been found by us. The TA3 cancer occurs as the non-strain specific Ha subline and as the strain-specific St subline. This is the first description of an N-like antigen in a non-primate as well as a tumor. This antigen reacts with Vicia anti-N. In serological specificity the Vicia agglutinin is closely related to the Thomsen-Friedenreich anti-T agglutinin present in most human and animal sera. These sera plus complement kill ordinary TA3-St cells and sialidase-treated Ha cells to less than 95 percent. Untreated TA3-Ha cells are fully resistant even though they absorb cytotoxin. Beta-galactosidase treatment of either Ha or St cells abolishes the killing activity of the sera. The cancer cells absorb anti-T but they lose this capability after exposure to beta-galactosidase. An immunological cross-relationship between the human blood-group MN antigens and the receptor for an oncogenic virus, the avian subgroup B leukosis sarcoma virus has been observed.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4142544

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  7 in total

1.  Depression of Thomsen-Friedenreich (anti-T) antibody in humans with breast carcinoma.

Authors:  G F Springer; P R Desai
Journal:  Naturwissenschaften       Date:  1975-06

2.  Increase in anti-T titer scores of breast-carcinoma patients following mastectomy.

Authors:  G F Springer; P R Desai
Journal:  Naturwissenschaften       Date:  1975-12

3.  Alterations in surface glycoproteins and level of sialyltransferase of cells transformed by a temperature-sensitive mutant of simian virus 40.

Authors:  K Onodera; N Yamaguchi; T Kuchino; Y Aoi
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

4.  Blood group MN specific substances and precursors in normal and malignant human breast tissues.

Authors:  G F Springer; P R Desai; I Banatwala
Journal:  Naturwissenschaften       Date:  1974-10

5.  Patients' immune response to breast and lung carcinoma-associated Thomsen-Friedenreich (T) specificity.

Authors:  G F Springer; S M Murthy; P R Desai; W A Fry; H Tegtmeyer; E F Scanlon
Journal:  Klin Wochenschr       Date:  1982-02-01

6.  Detection of lung- and breast carcinoma by quantitating serum anti-T IgM levels with a sensitive, solid-phase immunoassay.

Authors:  G F Springer; P R Desai
Journal:  Naturwissenschaften       Date:  1982-07

7.  In vivo localization of radioiodinated peanut lectin in a murine TA3/Ha mammary carcinoma model.

Authors:  A Shysh; S M Eu; A A Noujaim; M R Suresh; B M Longenecker
Journal:  Eur J Nucl Med       Date:  1985
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.